Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Bruce Kramer, M.D.

Co-Author

This page shows the publications co-authored by Daniel Kramer and Aaron Kesselheim.
Connection Strength

6.164
  1. Trust and transparency in medical device regulation. BMJ. 2019 06 18; 365:l4166.
    View in: PubMed
    Score: 0.821
  2. Coverage of Magnetic Resonance Imaging for Patients With Cardiac Devices: Improving the Coverage With Evidence Development Program. JAMA Cardiol. 2017 07 01; 2(7):711-712.
    View in: PubMed
    Score: 0.716
  3. The Watchman saga--closure at last? N Engl J Med. 2015 Mar 12; 372(11):994-5.
    View in: PubMed
    Score: 0.610
  4. Postmarket surveillance of medical devices: a comparison of strategies in the US, EU, Japan, and China. PLoS Med. 2013; 10(9):e1001519.
    View in: PubMed
    Score: 0.552
  5. The medical device excise tax--over before it begins? N Engl J Med. 2013 09 05; 369(10):984-5.
    View in: PubMed
    Score: 0.550
  6. The medical device excise tax--over before it begins? N Engl J Med. 2013 May 09; 368(19):1767-9.
    View in: PubMed
    Score: 0.536
  7. User fees and beyond--the FDA Safety and Innovation Act of 2012. N Engl J Med. 2012 Oct 04; 367(14):1277-9.
    View in: PubMed
    Score: 0.516
  8. How does medical device regulation perform in the United States and the European union? A systematic review. PLoS Med. 2012; 9(7):e1001276.
    View in: PubMed
    Score: 0.509
  9. Regulation of medical devices in the United States and European Union. N Engl J Med. 2012 Mar 01; 366(9):848-55.
    View in: PubMed
    Score: 0.493
  10. Landscape of Cardiovascular Device Registries in the United States. J Am Heart Assoc. 2019 06 04; 8(11):e012756.
    View in: PubMed
    Score: 0.204
  11. Medical device postapproval safety monitoring: where does the United States stand? Circ Cardiovasc Qual Outcomes. 2015 Jan; 8(1):124-31.
    View in: PubMed
    Score: 0.151
  12. FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012. JAMA. 2014 Jan 22-29; 311(4):385-91.
    View in: PubMed
    Score: 0.141
  13. Approval of high-risk medical devices in the US: implications for clinical cardiology. Curr Cardiol Rep. 2014; 16(6):489.
    View in: PubMed
    Score: 0.141
  14. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2011 Apr 01; 107(7):1071-1075.e5.
    View in: PubMed
    Score: 0.115
  15. Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment. Heart Rhythm. 2010 Nov; 7(11):1537-42.
    View in: PubMed
    Score: 0.111
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.